Evidence map›Paper›PMID 34770756›Full record

ArticleMolecules (Basel, Switzerland)2021

The Spasmolytic, Bronchodilator, and Vasodilator Activities of

Musaddique Hussain, Hazoor Bakhsh, Shahzada Khurram Syed, Malik Saad Ullah, Ali M Alqahtani, Taha Alqahtani, Afaf A Aldahish, Talha Bin Emran, Kashif Ur Rehman, Khalid Hussain Janbaz

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Musaddique HussainFaculty of Pharmacy, The Islamia University of Bahawulpur, Bahawulpur 63100, Pakistan.
Hazoor BakhshFaculty of Pharmacy, Bahauddin Zakariya University, Multan 66000, Pakistan.
Shahzada Khurram SyedDepartment of Basic Medical Sciences, School of Health Sciences, University of Management and Technology, Lahore 54000, Pakistan.ORCID 0000-0002-9412-9897
Malik Saad UllahDepartment of Pharmaceutical Chemistry, Government College University, Faisalabad 38000, Pakistan.
Ali M AlqahtaniDepartment of Pharmacology, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.ORCID 0000-0002-2240-4757
Taha AlqahtaniDepartment of Pharmacology, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.ORCID 0000-0003-4017-8754
Afaf A AldahishDepartment of Pharmacology, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.ORCID 0000-0002-5073-2088
Talha Bin EmranDepartment of Pharmacy, BGC Trust University Bangladesh, Chittagong 4381, Bangladesh.ORCID 0000-0003-3188-2272
Kashif Ur RehmanFaculty of Pharmacy, The Islamia University of Bahawulpur, Bahawulpur 63100, Pakistan.
Khalid Hussain JanbazFaculty of Pharmacy, Bahauddin Zakariya University, Multan 66000, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBiological ProductsBronchodilator AgentsCalcium Channel BlockersChromatography, High Pressure LiquidDose-Response Relationship, DrugMiceMolecular StructureMuscarinic AntagonistsParasympatholyticsParmeliaceaeSpectrum AnalysisToxicity Tests, AcuteVasodilator AgentsBiological ProductsBronchodilator AgentsCalcium Channel BlockersMuscarinic AntagonistsParasympatholyticsVasodilator Agentsacute toxicitybronchodilatorCa+2 antagonistParmotremaperlatumspasmolyticvasodilator

Identifiers

PMID34770756
PMCPMC8588472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.